Skip to main content

Table 2 Actions proposed by the WHO Regional Committee for Africa [36]

From: Combating poor-quality anti-malarial medicines: a call to action

Prioritize the development of medical products regulation

Strengthen the coherence and performance of the medicines regulatory system (including dialogue among stakeholders)a

Adapt and use guidelines in line with WHO recommendations

Increase implementation of regulatory functions

Enhance the status of NMRAs

Institute sustainable mechanisms to effectively manage conflicts of interest

Strengthen inter-sectoral collaboration between relevant stakeholders

Ensure availability of qualified human resources for regulation of medical products

Ensure adequate and sustainable financing of the medicines regulatory system

Improve collaboration, coordination, and harmonization of medical products regulation

  1. aDefined as NMRAs, manufacturers, traders, consumers and other representatives of civil society, health professionals, researchers, police, customs, the judiciary, governments, and parliamentarians